Serono Reports Q1 2005 Results Rebif(R) US Market Share at All-Time High and Raptiva(R) Now Reimbursed in 12 Countries GENEVA, Switzerland, April...
Serono Announces Discontinuation of Onercept in Moderate-to-Severe Psoriasis and Canvaxin(TM) in Stage IV Melanoma GENEVA, April 5...
Serono and Syntonix Sign Worldwide Agreement to Develop and Commercialize an Inhaleable Interferon-Beta Therapy for Multiple Sclerosis GENEVA...
Serono Announces Major Milestone in Identifying the Genes Involved in Multiple Sclerosis Identification of 80 Genes Involved in the Inflammatory...
Serono Reports Strong Full Year 2004 Results Total Revenues Grew 21.8% and EPS Increased 31.3% ROCKLAND, Massachusetts, February 1...
Serono and IVAX to Initiate Phase III Clinical Trial of Mylinax(R) in Multiple Sclerosis Mylinax(R) Targeted to Become First Oral Therapy for...
Serono Announces the Availability of Saizen(r) for Adult Growth Hormone Deficiency (AGHD) in the United States Needle-Free Delivery Option...
Serono Completes Patient Enrollment in Rebif(R) Versus Copaxone(R) Comparative Clinical Trial Head-to-Head Trial Will Provide Data on the...
Serono Announces FDA Approval of Rebif(R) Titration Pack Titration Pack Designed to Improve Convenience and Dose Accuracy for People Starting...
Serono and Micromet to Collaborate in Development and Commercialization of Novel Anti-Cancer Drug Agreement for MT201, Currently in Phase II...
Serono Launches 'My Fertility Profile' Customized Assessment of Fertility Health Now Online ROCKLAND, Mass., Nov. 22 /PRNewswire/ -- Serono...
Serono and Nautilus Biotech Sign Worldwide Agreement to Develop and Commercialize a Next-Generation Growth Hormone GENEVA, Switzerland and PARIS...
Serono Announces Appointment of New Chief Financial Officer GENEVA, Switzerland, November 10 /PRNewswire-FirstCall/ -- Serono (virt-x: SEO and...
Paratek Pharmaceuticals Presents Multiple Sclerosis Data at Society for Neuroscience Annual Meeting Non-Antibacterial Tetracyclines Demonstrate...
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.